KKR Pulls the Trigger on $2.8 Billion Deal for WebMD

By Paul Ausick Updated Jan 12, 9:51AM EST · Published Jul 24, 10:50AM EDT

Follow 24/7 Wall St. on Google

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Weekend chatter turned out to be right this time. KKR & Co. L.P. (NYSE: KKR) announced Monday morning that its Internet Brands portfolio company has agreed to acquire WebMD Health Corp. (NASDAQ: WBMD) in a transaction valued at around $2.8 billion. Internet Brands is paying $66.50 per share in cash for the online health information services, a premium of about 20% to Friday’s closing price of $55.19 and around 30% based on WebMD’s closing price on February 15, when the firm first announced that it was exploring strategic alternatives.

Internet Brands will commence a tender offer within 10 days to acquire all WebMD’s outstanding stock. The investment firm said funding for the transaction is fully committed and that the transaction is expected to close in the fourth quarter of this year.

Internet Brands operates in four areas: automotive, health, legal, and home and travel. The company’s health services include websites DentalPlans.com, eHealth Forum, HealthBoards, FitDay and VeinDirectory.org. Singapore’s sovereign wealth fund, Temasek, is KKR’s partner in Internet Brands.

[nativounit]

WebMD Chairman Martin J. Wygod said:

After a thorough review of strategic alternatives, we are pleased to announce this transaction, which provides our stockholders with immediate and significant cash value and a substantial premium. Throughout this process, our Board has conducted diligent analysis and thoughtful deliberations. WebMD and its financial advisors had a process that involved outreach to more than 100 strategic and financial parties, and we are confident that this transaction maximizes value for our stockholders.

WebMD merged with Healtheon in 1999 in a swap merger valued at about $5.5 billion. Recent cutbacks in pharmaceuticals advertising combined with overall uncertainty on federal health care policy led the company to forecast lower revenues for this year and to begin looking for a buyer.

WebMD stock traded at $66.00 Monday morning, up 19.6% compared with Friday’s closing price. The stock’s 52-week low is $48.10, and the high of $66.06 was posted early this morning.

[wallst_email_signup]

About the Author Paul Ausick →

Paul Ausick has been writing for a673b.bigscoots-temp.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.

He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.